0000950123-24-001863.txt : 20240213 0000950123-24-001863.hdr.sgml : 20240213 20240213160604 ACCESSION NUMBER: 0000950123-24-001863 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 EFFECTIVENESS DATE: 20240213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPM BioImpact LLC CENTRAL INDEX KEY: 0001687078 ORGANIZATION NAME: IRS NUMBER: 364818254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20107 FILM NUMBER: 24625776 BUSINESS ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: BioImpact Capital LLC DATE OF NAME CHANGE: 20210831 FORMER COMPANY: FORMER CONFORMED NAME: MPM Oncology Impact Management LP DATE OF NAME CHANGE: 20161007 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001687078 XXXXXXXX 12-31-2023 12-31-2023 false MPM BIOIMPACT LLC
399 BOYLSTON STREET, SUITE 1100 BOSTON MA 02116
13F HOLDINGS REPORT 028-20107 000309865 801-119133 N
Brendan Furey Chief Compliance Officer (617) 425-9203 /s/Brendan Furey Boston MA 02-13-2024 0 32 427428816 false
INFORMATION TABLE 2 30484.xml INFORMATION TABLE FOR FORM 13F Adaptimmune Therapeutics plc Sponsored ADR 00653A107 4041058 5095912 SH SOLE 5095912 0 0 ALX Oncology Holdings Inc. Common 00166B105 18832262 1264759 SH SOLE 1264759 0 0 Amicus Therapeutics Inc. Common 03152W109 10158380 715883 SH SOLE 715883 0 0 Avadel Pharmaceuticals PLC Sponsored ADR 05337M104 9389602 664986 SH SOLE 664986 0 0 Axsome Therapeutics, Inc. Common 05464T104 7432671 93387 SH SOLE 93387 0 0 Crinetics Pharmaceuticals Inc. Common 22663K107 17015566 478234 SH SOLE 478234 0 0 Cullinan Oncology, Inc. Common 230031106 77935851 7648268 SH SOLE 7648268 0 0 CYMABAY THERAPEUTICS INC Common 23257D103 14436095 611181 SH SOLE 611181 0 0 Disc Medicine Inc Common 254604101 2888000 50000 SH SOLE 50000 0 0 Geron Corporation Common 374163103 22609958 10715620 SH SOLE 10715620 0 0 Harpoon Therapeutics, Inc. Common 41358P205 3634648 319670 SH SOLE 319670 0 0 Inozyme Pharma Inc. Common 45790W108 1379443 323813 SH SOLE 323813 0 0 Insmed Incorporated Common 457669307 16367369 528150 SH SOLE 528150 0 0 Intellia Therapeutics, Inc. Common 45826J105 11665413 382598 SH SOLE 382598 0 0 Iovance Biotherapeutics Inc Common 462260100 26743391 3289470 SH SOLE 3289470 0 0 Karuna Therapeutics Inc Common 48576A100 16863336 53279 SH SOLE 53279 0 0 iTeos Therapeutics, Inc. Common 46565G104 19118076 1745943 SH SOLE 1745943 0 0 Madrigal Pharmaceuticals inc Common 558868105 9465756 40910 SH SOLE 40910 0 0 Moonlake Immunotherapeutics Class A Ord. 61559X104 17789445 294576 SH SOLE 294576 0 0 MORPHIC HOLDING INC Common 61775R105 9349669 323742 SH SOLE 323742 0 0 Olema Pharmaceuticals, Inc. Common 68062P106 26055618 1857136 SH SOLE 1857136 0 0 Phathom Pharmaceuticals inc Common 71722W107 639100 70000 SH SOLE 70000 0 0 REGENXBIO Inc. Common 75901B107 9855950 549078 SH SOLE 549078 0 0 Relay Therapeutics Inc. Common 75943R102 9160507 832017 SH SOLE 832017 0 0 Repare Therapeutics, Inc. Common 760273102 11970898 1639849 SH SOLE 1639849 0 0 Revolution Medicines, Inc. Common 76155X100 7841341 273408 SH SOLE 273408 0 0 Structure Therapeutics Inc. Sponsored ADS 86366E106 9403169 230696 SH SOLE 230696 0 0 Verve Therapeutics, Inc Common 92539P101 8895992 638163 SH SOLE 638163 0 0 VIKING THERAPEUTICS INC Common 92686J106 6053535 325284 SH SOLE 325284 0 0 Viridian Therapeutics Inc Common 92790C104 2178000 100000 SH SOLE 100000 0 0 Xeris Biopharma Holdings Inc Common 98422E103 9040995 3847232 SH SOLE 3847232 0 0 Werewolf Therapeutics, Inc. Common 95075A107 9217722 2388011 SH SOLE 2388011 0 0